Three Synthetic Cannabinoids Temporarily Placed as Schedule I Drugs

Submitted on Feb 23, 2015

Effective Jan. 30, 2015, the Administrator of the Drug Enforcement Administration (DEA) issued its final order to temporarily schedule three synthetic cannabinoids (SCs) into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA).

The substances are:

  1. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide (‘‘AB– CHMINACA’’)
  2. N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1-pentyl-1H-indazole- 3-carboxamide (‘‘AB–PINACA’’)
  3. [1-(5-fluoropentyl)-1H-indazol-3- yl](naphthalen-1-yl)methanone (‘‘THJ–2201’’)

This action is based on a finding by the Administrator that the placement of these synthetic cannabinoids and their optical, positional, and geometric isomers, salts, and salts of isomers into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle these SCs.

Read the full Federal Register.